Prevalence and Evolution of Right Ventricular Dysfunction Among Different Genetic Backgrounds in Dilated

Paolo Manca1, Antonio Cannatà2, Vincenzo Nuzzi1

  • 1Department of Cardiology, Azienda Sanitaria Universitaria Integrata Giuliano Isontina, University of Trieste, Trieste, Italy.

Insights

Titin (TTN)-related dilated cardiomyopathy (DCM) patients show better right ventricular dysfunction (RVD) recovery than other genetic DCM types. RVD evolution varies by genetic cause, with TTN-related DCM offering a higher chance of RVD improvement.

Area of Science:

  • Cardiology
  • Genetics
  • Heart Failure

Background:

  • Dilated cardiomyopathy (DCM) is a heterogeneous heart muscle disease.
  • Titin (TTN)-related DCM is linked to better left ventricular reverse remodeling.
  • Data on right ventricular dysfunction (RVD) evolution in DCM based on genetic background are lacking.

Purpose of the Study:

  • To investigate the evolution of RVD in DCM patients based on their genetic etiology.
  • To compare RVD recovery and right ventricular fractional area change (RVFAC) in TTN-related DCM versus other genetic DCM.
  • To assess the impact of RVD evolution on clinical outcomes.

Main Methods:

  • Analysis of 104 DCM patients with confirmed genetic variants (51 TTN-related, 53 other) and 139 controls.
  • RVD defined as RVFAC < 35%.
  • Follow-up data at 12-24 months to track RVD and RVFAC changes.

Main Results:

  • RVD was initially present in 29.1% of genetically positive DCM patients without significant differences between groups.
  • At follow-up, only 5.9% of TTN-related DCM patients had residual RVD compared to 35.8% in other genetic DCM (P < 0.001).
  • RVFAC significantly improved in TTN-related DCM but remained impaired in other genetic DCM cohorts.

Conclusions:

  • The evolution of RVD in DCM is heterogeneous and depends on the genetic background.
  • TTN-related DCM is associated with a significantly higher likelihood of RVD recovery compared to other genetic DCM etiologies.
  • RVD evolution did not significantly impact the composite outcome measure after adjustment.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
91
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
102
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
129
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
144
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
107
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
114